Total Company Value: Notable Labs, Ltd. (NTBL)

Notable Labs, Ltd. (NTBL) creates personalized therapy regimens using a functional analysis system to select optimal medications based on the reaction of a patient's live cells. Physicians value the project for its innovative AI forecasting, while it maintains its status as a promising venture startup. The market capitalization trend, which reached , highlights R&D complexities, stringent FDA oversight, and the high entry barriers of the PPMP platform.

NTBL Notable Labs Inc.: Enterprise Value in the range 07/04/2022 - 10/28/2026

Enterprise Value aggregates market capitalization and net debt, determining the total cost of acquiring control over assets while accounting for all liabilities. For Notable Labs, Ltd. (NTBL), which is currently developing IT platforms and consuming capital without a stable cash flow, the current enterprise value reflects the cost of investment risk and the expenses required to maintain business operations.

Direct competitors

Aggregate Business Value BeiGene Ltd. ONC|HALO - Enterprise Value|RVMD: Total Company Value|Ascentage Pharma Group (AAPG) - Total Company Value|cgoncology.com (CGON) - Total Company Value|Enterprise Value URGN|Real Price to Acquire Entire Company Bicara Therapeutics Inc|Enterprise Value PSNL|Enterprise Value ERAS (Erasca Oncology)|DCTH - Total Company Value|Business Value ymabs.com YMAB|AURA: Enterprise Value|CADL - Real Price to Acquire Entire Company|Enterprise Value ARAY|SLS (SELLAS Life Sciences Group) - Total Enterprise Value|ACTU - Total Company Value|Value Adjusted for Debt and Cash citiusonc.com (CTOR)|TuHURA Biosciences, Inc. (HURA) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash Protara Therapeutics Inc (TARA)|Fate Therapeutics Corp - Enterprise Value|WHWK - Real Price to Acquire Entire Company|TScan - Real Price to Acquire Entire Company|CSBR: Enterprise Value|Total Company Value xbiotech.com XBIT|CEL-SCI (CVM) - Value Adjusted for Debt and Cash|Enterprise Value OSTX (OS Therapies Inc)|Total Enterprise Value RADX|Total Company Value Artiva Biotherapeutics, Inc. ARTV|Business Value ANL (adlainortye.com)|VERU: Total Company Value|TPST - Total Enterprise Value|Real Price to Acquire Entire Company Xilio XLO|RENB - Aggregate Business Value|MURA: Enterprise Value|Kairos Pharma (KAPA) - Enterprise Value|Enterprise Value OnKure Therapeutics, Inc.|Total Company Value GDTC|Total Company Value Curis, Inc. (CRIS)|Total Company Value apollomicsinc.com (APLM)|THAR: Enterprise Value|ADVB - Total Enterprise Value|Real Price to Acquire Entire Company Genprex (GNPX)|CLDI: Value Adjusted for Debt and Cash|Sunshine Biopharma, Inc. (SBFM) - Total Company Value|Xenetic Biosciences, Inc. (XBIO) - Total Company Value|SLRX (Salarius Pharmaceuticals) - Enterprise Value|Enterprise Value purple-biotech.com|Enterprise Value American Oncology Network (AONC)|Total Company Value BGNE (BeiGene Ltd.)|Total Company Value CKPT|ELEV - Company Buyout Price|Real Price to Acquire Entire Company iCAD Corp (ICAD)|IKNA: Value Adjusted for Debt and Cash|viracta.com (VIRX) - Total Company Value|Total Company Value MorphoSys Inc|NAYA Bio (NAYA) - Real Price to Acquire Entire Company|Aggregate Business Value Ascentage